Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “hold” rating reaffirmed by investment analysts at Cantor Fitzgerald in a research note issued to investors on Friday. They presently have a $1,050.00 price target on the medical equipment provider’s stock. Cantor Fitzgerald’s target price suggests a potential upside of 13.21% from the stock’s current price.

The analysts wrote, “Procedure growth: Guidance for 2017 procedure growth appears to be conservative. ISRG had 17% procedure growth in the 1H and is guiding to 14-15% procedure growth for 2017, implying 11-13% procedure growth in the 2H. The first-half procedure growth came in above expectations, as gynecology (grew in low single digits) and urology (grew in mid-to-high single digits) and China (grew by well over 25%) outpaced expectations. Second-half guidance assumes slower growth in gynecology, urology, and China, one less selling day in 3Q, and lower growth in Japan due to a lack of reimbursement.””

Other equities analysts also recently issued research reports about the company. Barclays PLC restated a “buy” rating and issued a $800.00 target price on shares of Intuitive Surgical in a research report on Sunday, March 26th. Canaccord Genuity restated a “buy” rating and issued a $800.00 target price on shares of Intuitive Surgical in a research report on Friday, March 24th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $860.00 target price on the stock in a research report on Tuesday, April 18th. Stifel Nicolaus raised their target price on Intuitive Surgical from $800.00 to $850.00 and gave the company a “buy” rating in a research report on Wednesday, April 19th. Finally, Citigroup Inc. restated a “buy” rating and issued a $917.00 target price (up previously from $820.00) on shares of Intuitive Surgical in a research report on Saturday, April 22nd. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $953.97.

Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 927.47 on Friday. The stock has a market capitalization of $34.32 billion, a PE ratio of 44.42 and a beta of 0.39. Intuitive Surgical has a one year low of $610.71 and a one year high of $974.66. The stock’s 50 day moving average price is $934.93 and its 200 day moving average price is $803.42.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating the consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million for the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.51% and a net margin of 28.44%. The business’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.62 earnings per share. Equities research analysts predict that Intuitive Surgical will post $23.59 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/07/23/cantor-fitzgerald-reiterates-hold-rating-for-intuitive-surgical-inc-nasdaqisrg.html.

In other Intuitive Surgical news, Director Alan J. Levy sold 1,386 shares of the firm’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $813.15, for a total transaction of $1,127,025.90. Following the completion of the sale, the director now owns 2,598 shares of the company’s stock, valued at $2,112,563.70. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Mark J. Meltzer sold 3,000 shares of the firm’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $887.09, for a total value of $2,661,270.00. Following the sale, the senior vice president now directly owns 3,046 shares of the company’s stock, valued at approximately $2,702,076.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,041 shares of company stock valued at $24,493,708. 2.50% of the stock is owned by insiders.

Large investors have recently bought and sold shares of the company. D. Scott Neal Inc. acquired a new stake in Intuitive Surgical during the second quarter valued at about $120,000. Guardian Life Insurance Co. of America boosted its stake in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the period. Acropolis Investment Management LLC acquired a new stake in Intuitive Surgical during the first quarter valued at about $115,000. Parallel Advisors LLC boosted its stake in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares during the period. Finally, Huntington National Bank boosted its stake in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the period. 97.53% of the stock is owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.